• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铜-62-ATSM:一种具有高膜通透性和低氧化还原电位的新型缺氧显像剂。

Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.

作者信息

Fujibayashi Y, Taniuchi H, Yonekura Y, Ohtani H, Konishi J, Yokoyama A

机构信息

Department of Radiopharmaceutical Chemistry, Eukui Medical School, Japan.

出版信息

J Nucl Med. 1997 Jul;38(7):1155-60.

PMID:9225812
Abstract

UNLABELLED

An ideal hypoxia imaging agent should have high membrane permeability for easy access to intracellular mitochondria and low redox potential to confer stability in normal tissue, but it should be able to be reduced by mitochondria with abnormally high electron concentrations in hypoxic cells. In this context, nitroimidazole residues are not considered to be essential. In this study, Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM), a 62Cu-bisthiosemicarbazone complex, with high membrane permeability and low redox potential, was evaluated as a possible hypoxia imaging agent, using electron spin resonance spectrometry and the Langendorff isolated perfused rat heart model as well as rat heart left anterior descending occlusion model.

METHODS

Nonradioactive Cu-ATSM was incubated with rat mitochondria, after which reduction of Cu(II) to Cu(I) was measured with electron spin resonance. As a model of hypoxic mitochondria, rotenone (Complex I inhibitor)-treated mitochondria were used.

RESULTS

In this study, Cu-ATSM was reduced by hypoxic but not by normal mitochondria.

CONCLUSION

Thus, retention of 62Cu-ATSM was studied serially in perfused rat hearts under conditions of normoxia (95% O2 + 5% CO2), hypoxia (95% N2 + 5% CO2) and reoxygenation (95% O2 + 5% CO2). In normoxia and reoxygenation, 62Cu-ATSM injected as a single bolus showed low retention (23.77% and 22.80%, respectively) 15 min after injection, but retention was increased markedly under hypoxic conditions (81.10%). Also, in the in vivo left anterior descending occluded rat heart model, 62Cu-ATSM retention was inversely correlated with accumulation of 201Tl, a relative myocardial blood flow marker.

摘要

未标记

理想的缺氧显像剂应具有高膜通透性以便易于进入细胞内线粒体,且具有低氧化还原电位以在正常组织中保持稳定,但它应能够被缺氧细胞中电子浓度异常高的线粒体还原。在这种情况下,硝基咪唑残基不被认为是必需的。在本研究中,使用电子自旋共振光谱法、Langendorff离体灌注大鼠心脏模型以及大鼠心脏左前降支闭塞模型,评估了具有高膜通透性和低氧化还原电位的62Cu-双硫代半卡巴腙配合物Cu(II)-二乙酰基双(N4-甲基硫代半卡巴腙)(Cu-ATSM)作为一种可能的缺氧显像剂。

方法

将非放射性Cu-ATSM与大鼠线粒体孵育,然后用电子自旋共振测量Cu(II)还原为Cu(I)的情况。使用鱼藤酮(复合体I抑制剂)处理的线粒体作为缺氧线粒体的模型。

结果

在本研究中,Cu-ATSM被缺氧线粒体还原,但不被正常线粒体还原。

结论

因此,在常氧(95% O2 + 5% CO2)、缺氧(95% N2 + 5% CO2)和复氧(95% O2 + 5% CO2)条件下,对灌注大鼠心脏中62Cu-ATSM的滞留情况进行了连续研究。在常氧和复氧条件下,单次推注注射的62Cu-ATSM在注射后15分钟时显示出低滞留率(分别为23.77%和22.80%),但在缺氧条件下滞留率显著增加(81.10%)。此外,在体内左前降支闭塞大鼠心脏模型中,62Cu-ATSM的滞留与相对心肌血流标志物201Tl的蓄积呈负相关。

相似文献

1
Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.铜-62-ATSM:一种具有高膜通透性和低氧化还原电位的新型缺氧显像剂。
J Nucl Med. 1997 Jul;38(7):1155-60.
2
Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone).使用正电子发射断层扫描(PET)和铜(II)-二乙酰双(N(4)-甲基硫代半卡巴腙)描绘犬心肌中的缺氧情况。
J Nucl Med. 2002 Nov;43(11):1557-69.
3
Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).PET显像剂64Cu(II)-双乙酰双(N4-甲基硫代半卡巴腙)缺氧选择性的瘤间差异
J Nucl Med. 2006 Jun;47(6):989-98.
4
Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM.缺氧选择性核成像剂Cu-ATSM摄取和滞留的细胞系依赖性差异。
Nucl Med Biol. 2005 Aug;32(6):623-30. doi: 10.1016/j.nucmedbio.2005.05.003.
5
Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent cu-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells.缺氧选择性核成像/放射治疗剂铜-二乙酰双(N4-甲基硫代半卡巴腙)(Cu-ATSM)在肿瘤细胞中的保留机制。
Ann Nucl Med. 2001 Dec;15(6):499-504. doi: 10.1007/BF02988502.
6
Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.18F-氟阿霉素阿拉伯呋喃糖苷与 64Cu-二乙酰基双(N4-甲基硫代半卡巴腙)在癌症临床前模型中的比较。
J Nucl Med. 2013 Jul;54(7):1106-12. doi: 10.2967/jnumed.112.111120. Epub 2013 May 22.
7
Radiolabeled Cu-ATSM as a novel indicator of overreduced intracellular state due to mitochondrial dysfunction: studies with mitochondrial DNA-less ρ0 cells and cybrids carrying MELAS mitochondrial DNA mutation.放射性标记的 Cu-ATSM 作为线粒体功能障碍导致细胞内过度还原状态的新型标志物的研究:使用缺乏线粒体 DNA 的 ρ0 细胞和携带 MELAS 线粒体 DNA 突变的细胞杂种进行的研究。
Nucl Med Biol. 2012 Feb;39(2):177-85. doi: 10.1016/j.nucmedbio.2011.08.008. Epub 2011 Oct 26.
8
Cardiac hypoxia imaging: second-generation analogues of 64Cu-ATSM.心脏缺氧成像:64Cu-ATSM 的第二代类似物。
J Nucl Med. 2014 Mar;55(3):488-94. doi: 10.2967/jnumed.113.129015. Epub 2014 Jan 13.
9
Copper-62 ATSM as a hypoxic tissue tracer in myocardial ischemia.铜-62 乙酰半胱氨酸作为心肌缺血中的缺氧组织示踪剂。
Ann Nucl Med. 2001 Jun;15(3):293-6. doi: 10.1007/BF02987849.
10
Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats.Cu-64-ATSM与C-11-乙酸盐在急性心肌梗死模型中的对比研究:大鼠缺氧的离体成像
Nucl Med Biol. 1999 Jan;26(1):117-21. doi: 10.1016/s0969-8051(98)00049-3.

引用本文的文献

1
Relationship between renal oxidative stress levels and disease severity in patients with chronic kidney disease assessed by [Cu-64]ATSM PET/MRI.通过[铜-64]ATSM正电子发射断层扫描/磁共振成像评估慢性肾脏病患者肾脏氧化应激水平与疾病严重程度之间的关系。
Sci Rep. 2025 Feb 28;15(1):7227. doi: 10.1038/s41598-024-85027-2.
2
Radiocopper in Radiopharmacy and Medical Use: Current Status and Perspective.放射性药物学与医学应用中的放射性铜:现状与展望
J Med Chem. 2025 Feb 13;68(3):2356-2376. doi: 10.1021/acs.jmedchem.4c02885. Epub 2025 Feb 2.
3
Additive Effects of Cu-ATSM and Radiation on Survival of Diffuse Intrinsic Pontine Glioma Cells.
铜-ATSM与辐射对弥漫性脑桥内在神经胶质瘤细胞存活的相加效应
Radiat Res. 2025 Jan 1;203(1):10-17. doi: 10.1667/RADE-24-00076.1.
4
Zirconium 89 and Copper 64 for ImmunoPET: From Antibody Bioconjugation and Radiolabeling to Molecular Imaging.用于免疫正电子发射断层显像的锆-89和铜-64:从抗体生物偶联与放射性标记到分子成像
Pharmaceutics. 2024 Jun 30;16(7):882. doi: 10.3390/pharmaceutics16070882.
5
Hemoglobin Microbubbles and the Prediction of Different Oxygen Levels Using RF Data and Deep Learning.血红蛋白微泡以及利用射频数据和深度学习预测不同氧水平
Proc SPIE Int Soc Opt Eng. 2023 Feb;12470. doi: 10.1117/12.2655121. Epub 2023 Apr 10.
6
Evidence for disrupted copper availability in human spinal cord supports Cu(atsm) as a treatment option for sporadic cases of ALS.人类脊髓中铜可利用性紊乱的证据支持Cu(atsm)作为散发性肌萎缩侧索硬化症病例的一种治疗选择。
Sci Rep. 2024 Mar 11;14(1):5929. doi: 10.1038/s41598-024-55832-w.
7
Assessment of hypoxia and oxidative-related changes in a lung-derived brain metastasis model by [Cu][Cu(ATSM)] PET and proteomic studies.通过[铜][铜(ATSM)]正电子发射断层扫描(PET)和蛋白质组学研究评估肺源性脑转移模型中的缺氧和氧化相关变化。
EJNMMI Res. 2023 Nov 25;13(1):102. doi: 10.1186/s13550-023-01052-8.
8
Radiometals in Imaging and Therapy: Highlighting Two Decades of Research.成像与治疗中的放射性金属:二十年来的研究亮点。
Pharmaceuticals (Basel). 2023 Oct 13;16(10):1460. doi: 10.3390/ph16101460.
9
Functional Imaging of Hypoxia: PET and MRI.缺氧的功能成像:正电子发射断层扫描(PET)和磁共振成像(MRI)
Cancers (Basel). 2023 Jun 25;15(13):3336. doi: 10.3390/cancers15133336.
10
In vitro and in vivo characterization of [Cu][Cu(elesclomol)] as a novel theranostic agent for hypoxic solid tumors.新型乏氧实体瘤诊疗剂[Cu][Cu(依来氯铵)]的体外和体内特性研究
Eur J Nucl Med Mol Imaging. 2023 Oct;50(12):3576-3588. doi: 10.1007/s00259-023-06310-4. Epub 2023 Jun 29.